Russia Losing a Generation to Heroin
Robert Amsterdam (September 25th, 2009) Writes:
Robert Amsterdam (September 25th, 2009) Writes:
Michael Vlaicu (September 11th, 2009) Writes:
Nutra Pharma Corp.
(Public, OTC:NPHC)
Step aside Morphine, the new king of chronic pain treatment has entered the building. With Nutra Pharma’s stock rising nearly 2300% year-to-date, its time we see what all the commotion is about. StocksHaven Investments takes a closer look at Nutra Pharma Corp., which believes will begin generating significant revenues within the next 12 months. The company has recently made waves throughout the biotech space with their recent “Best New Product” award winning drug, Cobroxin. The product is the first clinically proven treatment for stage 2 (moderate to severe) chronic pain, and was awarded the honour at the Efficient Collaborative Retail Marketing (ECRM) Conference in Miami, Florida. Winning this was no easy task, as a handful of well known companies attended the conference. The
...
Jim Musselwhite (March 11th, 2009) Writes:
Elliott Wave International, the world’s largest market forecasting firm, receives thousands of questions every year from web site visitors and subscribers on their free Message Board.
Here the company shares 6 of the recent critical questions on the financial crisis and 6 answers provided by their professional analysts.
For more free questions and answers or to submit your own question, visit Elliott Wave International’s Message Board.
Q: Can increased government spending help stop the crisis?
What do you think about the new mortgage bailout plan – or bailouts and proposals for additional government spending in general? The opinions on whether or not this will ultimately work seem so divided…
Answer:
In Ch. 13 of his Conquer the Crash, “Can the Fed Stop Deflation?”, Bob Prechter writes; quote: “Can the government spend our way out of deflation and depression? Governments sometimes employ aspects …